mRNA |
3-Cl-AHPC |
CTRPv2 |
pan-cancer |
AAC |
-0.034 |
0.4 |
mRNA |
cabozantinib |
CTRPv2 |
pan-cancer |
AAC |
-0.037 |
0.4 |
mRNA |
HLI 373 |
CTRPv2 |
pan-cancer |
AAC |
-0.035 |
0.4 |
mRNA |
5-FU |
CTRPv2 |
pan-cancer |
AAC |
0.033 |
0.4 |
mRNA |
OSI-027 |
CTRPv2 |
pan-cancer |
AAC |
-0.035 |
0.4 |
mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.033 |
0.4 |
mRNA |
PDMP |
CTRPv2 |
pan-cancer |
AAC |
-0.037 |
0.4 |
mRNA |
ouabain |
CTRPv2 |
pan-cancer |
AAC |
-0.034 |
0.4 |
mRNA |
QS11 |
CTRPv2 |
pan-cancer |
AAC |
-0.071 |
0.4 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.035 |
0.4 |